bibliographic entry 11398848 [be/11398848]
https://w3id.org/oc/corpus/be/11398848

is a

• bibliographic reference

content

• Roden M, Weng J, Eilbracht J et al. Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double‐blind, placebo‐controlled, phase 3 trial. Lancet Diabetes Endocrinol 2013; 1: 208–219. PMID: 24622369

references

• https://w3id.org/oc/corpus/br/1365071